Dec 30 (Reuters) - MedMira Inc MIR.V :
* ANNOUNCES ITS VALIDATED REVEALCOVID-19 PLUS TOTAL ANTIBODY TEST FOR DETECTION OF TOTAL ANTIBODIES AGAINST SARS-COV-2
* REVEALCOVID-19(TM) PLUS TOTAL ANTIBODY TEST IS AN UPDATE TO MEDMIRA'S REVEALCOVID-19(TM) TOTAL ANTIBODY TEST
* A NEW EUA APPLICATION WILL BE SUBMITTED TO U.S. FDA WITHIN 10 BUSINESS DAYS
* CO WILL SUBMIT NEW INTERIM ORDER APPLICATION TO SEEK HEALTH CANADA AUTHORIZATION OF REVEALCOVID-19(TM) PLUS TOTAL ANTIBODY TEST